Journals / Anadolu Psikiyatri Dergisi / 2014 / Cilt: 15 - Sayı: 4

Investigation of mindfulness and affecting factors of mindfulness among substance users and non users

Bağımlı olan ve olmayan bireylerde farkındalık (mindfulness) ve farkındalığı etkileyen etkenlerin incelenmesi

Pages
282–288
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The significantly different levels of factors which affect the mindfulness observed in the addicted group indicate that the Mindfulness therapy might be beneficial in addiction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate the factors which affect the mindfulness and trying to determine the role of mindfulness on addiction.
📊
Key Findings & Data:Mindful Attention Awareness Scale (MAAS), General Health Questionnaire (GHQ), White Bear Suppression Inventory (WBSI), Meta-cognitions questionnaire (MCQ-30), The Emotion Regulation Questionnaire (ERQ), MMPI Impulsivity Scale (IMP), SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders were administered to the participants.
💡
Conclusion & Impact:The significantly different levels of factors which affect the mindfulness observed in the addicted group indicate that the Mindfulness therapy might be beneficial in addiction.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to investigate the factors which affect the mindfulness and trying to determine the role of mindfulness on addiction. In this regard, the aim is to review the use of practicing mindfulness based therapies in the treatment.Methods: One hundred ninety one patients who have been taking treatment in Alcohol and Substance Addiction/Abuse Research and Treatment Center were included in the substance users group. A total of one hundred people, comprised of seventy five teachers and twenty five bank clerks, were included in the non-users group. Mindful Attention Awareness Scale (MAAS), General Health Questionnaire (GHQ), White Bear Suppression Inventory (WBSI), Meta-cognitions questionnaire (MCQ-30), The Emotion Regulation Questionnaire (ERQ), MMPI Impulsivity Scale (IMP), SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders were administered to the participants. Results: There were no significant differences of mindfulness levels between the addicted and non-addicted groups. When two groups were compared, statistically significant differences of IMP, WBSI, MCQ-30, ERQ suppression subscale and GHQ levels were observed. Lower levels of mindfulness were observed on users who did not receive any treatment in the past and users of non-alcoholic substances.Conclusion: In light of the results of this study, it was determined that albeit the significant differences between the levels of factors which are known to affect mindfulness, including metacognition, repression, impulsivity and physical problems, between groups, there was insignificant difference of mindfulness level observed in both the addicted and non-addicted groups, and this observation was deemed a trace of MAAS scale failing to properly measure the Mindfulness level. The significantly different levels of factors which affect the mindfulness observed in the addicted group indicate that the Mindfulness therapy might be beneficial in addiction.

Özet

Amaç: Bu çalışmanın amacı, farkındalığı etkileyen etkenleri araştırmak ve farkındalığın bağımlılık üzerindeki rolünü anlamaya çalışmaktır.. Bu açıdan, farkındalık temelli terapilerin tedavide kullanımını da gözden geçirmektir.Yöntem: Çalışmanın bağımlı grubuna, Alkol ve Madde Bağımlılığı Tedavi ve Eğitim Merkezinde yatarak tedavi görmekte olan 191 kişi, bağımlı olmayan grubuna ise 75 öğretmen, 25 banka memuru, 100 kişi dahil edilmiştir. Katılımcılara, Bilinçli Farkındalık Ölçeği (BFÖ), Genel Sağlık (GSA), Beyaz Ayı Supresyon Ölçeği (BAS), Üst Biliş Ölçeği-30 (ÜBÖ-30), Duygu Düzenleme Ölçeği (DDÖ), Dürtüsel Davranışlar Alt Ölçeği (DDAÖ), DSM-IV-TR için yapılandırılmış klinik görüşme formu uygulanmıştır. Bulgular: Farkındalık düzeyi, bağımlı olan ve olmayan grup arasında farklı bulunmamıştır. İki grup karşılatırıldığında DDAÖ, BASÖ, ÜBÖ-30, DDÖ bastırma alt ölçeği ve GSA arasında istatistiksel olarak anlamlı fark bulunmuştur. Ayrıca, daha önce tedavi görmeyen ve alkol dışı madde kullanan bağımlılarda farkındalık düzeyi daha düşüktür. Sonuç: Bağımlı olan ve olmayan grup arasında farkındalık düzeyinde fark bulunmaması ancak farkındalığı etkilediği bilinen üst biliş, bastırma, dürtüsellik, fiziksel sorunlarda fark gözlenmesinin, araştırmanın örneklem seçimindeki sosyodemografik farklılıklardan kaynaklanabileceği ve BFÖ"nün ölçtüğü düşünülen farkındalığı tüm yönleriyle ölçemediğini de düşünülmüştür. Yine de farkındalığı etkileyen etkenlerin bağımlı grupta farklı bulunması, bağımlılıkta farkındalık terapisinin yararlı olabileceği izlenimini vermektedir.

🔖

Cite This Article

ÖGEL, K., SARP, N., TAMAR, D. G., ERMAĞAN, E. (2014). Investigation of mindfulness and affecting factors of mindfulness among substance users and non users. Anadolu Psikiyatri Dergisi, Cilt: 15 - Sayı: 4, 282–288. https://ajindex.com/articles/355818

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bishop SR, Lau M, Shapiro S, Carlson L, Car- mody J, Zindel VS, et al. Mindfulness: a pro- posed operational definition. Clin Psychol Sci Pract, Health Module 2004; 8(Suppl.11):3,230. Kabat-Zin J. Full Catastrophy Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. New York: Dell, 1990. Kabat-Zinn J. Wherever You Go There You Are. Fourth ed., New York: Hyperion, 1994. Astin JA. Stress reduction through mindfulness meditation: Effects on psychological symptom- tology, sense of control, and spiritual experi- ences. Psychother Psychosom 1997; 66:97-106.
  2. Marcus MT, Zgierska A. Mindfulness-based therapies for substance use disorders: part 1. Subst Abuse 2009; 30:263-265.
  3. Çatak PD, Ögel K. Bir terapi yöntemi olarak farkındalık. Nöropsikiyatri Arşivi 2010; 47:69-73.
  4. Çatak PD, Ögel K. Farkındalık temelli terapiler ve terapötik süreçler. Klinik Psikiyatri 2010; 13:85- 91. Wells A. GAD, metacognition, and mindfulness: an information processing analysis. Clin Psychol Sci Pract 2002; 9:95-100.
  5. Corcoran KM, Segal ZV. Metacognition in de- pressive and anxiety disorders: current direc- tions. Int J Cogn Ther 2008; 1:33-44.
  6. Coffey KA, Hartman M. Mechanisms of action in the inverse relationship between mindfulness and psychological distress. Comp Health Prac Rev 2008; 13:79-91.
  7. Roemer L, Lee JK, Salters-Pedneault K, Erisman SE, Orsillo SM, Mennin DS. Mindfulness and emotion regulation difficulties in generalized anxi- ety disorder: Preliminary evidence for indepen- dent and overlapping contributions. Behav Ther 2008; 40:142-154.
  8. Murphy C, Mackillop J. Living in the here and now: interrelationships between impulsivity, mindfulness, and alcohol misuse. Psychophar- macology (Berl) 2012; 219(Suppl.2):527-536.
  9. Brown KW, Ryan RM. The benefits of being present: mindfulness and ıts role in psychological well-being. 84(Suppl.4):822-848. Soc Psychol 2003; Hoppes K. The application of mindfulness-based cognitive interventions in the treatment of co- occurring addictive and mood disorders. CNS Spectrums 2006; 11(Suppl.11):829-851.
  10. Witkiewitz K, Marlatt GA, Walker D. Mindfulness- based relapse prevention for alcohol and sub- stance use disorders. J Cognit Psychother 2005; 19(Suppl.3):211-228.
  11. Alterman AI, Koppenhaver JM, Mulholland E, Ladden LJ, Baime MJ. Pilot trial of effectiveness of mindfulness meditation for substance abuse patients. J Subst Use 2004; 9(Suppl.6):259-268.
  12. Bowen S, Chawla N, Collins SE, Witkiewitz K, Hsu S, Grow J, et al. Mindfulness-bas